Debridement using Piezosurgical Device and Incorporation of Autologous Platelet-Rich Fibrin in Management of Stage III Medication-Related Osteonecrosis of the Jaw — A Case study and Review of Literature

Ruggiero SI, Dodson TB, Fantasia J et al (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72:1938–1956

Article  PubMed  Google Scholar 

NH Beth-Tasdogan, B Mayer, H Hussein, O Zolk. 2017 Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev, Issue 10. Art. No.: CD012432. DOI: https://doi.org/10.1002/14651858.CD012432.pub2

Khosla S et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research. J Bone Miner Res 22:1479–1491. https://doi.org/10.1359/JBMR.0707ONJ

Article  PubMed  Google Scholar 

Del Fabbro Massimo, Gallesio Giorgia, Mozzati Marco (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51:62–74

Article  PubMed  Google Scholar 

Hong Mu, Pang Y, Liu L, Liu J, Liu C (2023) Clinical values of serum Semaphorin 4D (Sema4D) in medication-related osteonecrosis of the jaw. Eur J Med Res 28:140

Article  Google Scholar 

James R Berenson, Alison T Stopeck. Medication related osteonecrosis of the jaw in patients with cancer UpToDate – 2017. J Clin Onco 29(17):e521–22

Ristow Oliver et al (2019) Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. J Cranio-Maxillo-Facial Surg 47:491–499

Article  Google Scholar 

Dohan DM, Choukroun J, Diss A et al (2006) Platelet-Rich Fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e45–e50

Article  PubMed  Google Scholar 

Kim J-W, Kim S-J, Kim M-R (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52:854–859. https://doi.org/10.1016/j.bjoms.2014.07.256

Article  PubMed  Google Scholar 

Lo JC, O’Ryan FS, Gordon NP et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243

Article  PubMed  Google Scholar 

Yamashita J, McCauley LK (2012) Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract 12:233

Article  PubMed  Google Scholar 

Hellstein JW, Adler RA, Edwards B et al (2011) Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 142:1243

Article  CAS  PubMed  Google Scholar 

Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117

Article  CAS  PubMed  Google Scholar 

Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193

Article  CAS  PubMed  Google Scholar 

Sedghizadeh PP, Kumar SK, Gorur A et al (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66:767

Article  PubMed  Google Scholar 

Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M (2012) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48:469–474

Article  PubMed  Google Scholar 

Gurav Sandeep, Dholam Kanchan P, Singh Gurkaran Preet (2022) Treatment of refractory medicine related osteonecrosis of jaw with piezosurgical debridement and autologous platelet rich fibrin: feasibility study. J Craniofac SurgMay 33(3):e226–e230. https://doi.org/10.1097/SCS.0000000000007981

Article  Google Scholar 

Blus C, Giannelli G, Szmukler-Moncler S, Orru G (2016) Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery A case series of 20 treated sites. Oral Maxillofacial Surg 21(1):41–48. https://doi.org/10.1007/s10006-016-0597-7

Article  Google Scholar 

Bilimoria R, Young H, Patel D, Kwok J (2017) The role of piezoelectric surgery and platelet rich fibrin in treatment of ORN and MRONJ: a clinical case series. Oral Surg 11(2):136–143. https://doi.org/10.1111/ors.12318

Article  Google Scholar 

Pavlíková G, Foltán R, Horká M, Hanzelka T, Borunská H, Šedý J (2011) Piezosurgery in oral and maxillofacial surgery. Int J Oral Maxillofac Surg 40(5):451–457

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif